MedPath

Ultrafine Particles and Fetal Contamination

Completed
Conditions
Lung; Premature
Pollution; Exposure
Registration Number
NCT04068389
Lead Sponsor
University Hospital, Bordeaux
Brief Summary

The objective of this study is to evaluate the transplacental passage of fine and ultrafine particles (nanoparticles) inhaled by the mother.

Detailed Description

Epidemiological studies have demonstrated the harmful effects of particulate air pollution on the progress of pregnancy and postnatal health.

Experimental studies have suggested the transplacental passage of asbestos fibers, but despite the strong growth in the use and production of fine and ultrafine particles, no study has examined the permeability of the placenta to these compounds or the exposures fetuses that may result.

The objective of this study is to evaluate the transplacental passage of fine and ultrafine particles (nanoparticles) inhaled by the mother.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
62
Inclusion Criteria
  • All women volunteers for whom a medical termination of pregnancy is proposed for a fetus older than 22 weeks (weight over 500g).
Exclusion Criteria
  • Refusal of participation of the patient.
  • Fetus with malformation syndrome affecting pulmonary perfusion.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Presence of fine particles in fetal lung samples yes/noAt the screening

Analysis in electron microscopy

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath